MARY NANJO-ALLICOCK: Open Payments
NPI 1720621501 · NEW CASTLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 11 payments from 8 companies in 2025. Trend: 2023 $302 · 2024 $164 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $84 |
| Tactile Systems Technology Inc | 2 | $84 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| ABBVIE INC. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
Products named: Flexitouch Plus, ZEPBOUND, ROTATEQ, MAVYRET, INGREZZA, Cologuard Collection Kit, Veozah, Ozempic.
Industry payments across DE — which companies pay providers there.
